
OPINION: Lawsuit ads may harm NJ patients, stifle innovation
The basics: Jeanette Hoffman is the executive director of Patients Come First New Jersey. She writes that lawsuit ads may mislead patients to stop taking FDA-approved medications. Mass tort threats may slow medical innovation and drug development. You’ve …